GramEye Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
GramEye Inc. - overview
Established
2020
Location
Ibaraki-shi, Osaka, Japan
Primary Industry
Healthcare IT
About
Based in Osaka, Japan, and founded in 2020, GramEye Inc. develops medical devices that use Gram staining with robotics and deep learning to automate sample handling, process microscopic images, support clinical laboratory operations, and enable consistent analysis across microbiology workflows. In November 2025, GramEye Inc. raised JPY 570 million in series B funding from new investor Beyond Next Ventures with participation from existing investors Samurai Incubate and NES.
The company offers medical devices which automate gram staining along with deep learning and robotics. The firm develops artificial intelligence and robotics technology to resolve the problem of drug-resistant bacteria.
Current Investors
Deepcore, SMBC Venture Capital, Samurai Incubate
Primary Industry
Healthcare IT
Sub Industries
Bioinformatics, Healthcare IT
Website
https://grameye.com
Verticals
Artificial Intelligence, HealthTech, Robotics
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.